These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22507968)

  • 1. Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery.
    Wu Y; Wu S; Hou L; Wei W; Zhou M; Su Z; Wu J; Chen W; Ma G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):486-97. PubMed ID: 22507968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization.
    Wu Y; Wei W; Zhou M; Wang Y; Wu J; Ma G; Su Z
    Biomaterials; 2012 Mar; 33(7):2351-60. PubMed ID: 22192540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
    Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
    Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
    Tao W; Zheng HQ; Fu T; He ZJ; Hong Y
    Hum Vaccin Immunother; 2017 Aug; 13(8):1818-1822. PubMed ID: 28604244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.
    Croyle MA; Patel A; Tran KN; Gray M; Zhang Y; Strong JE; Feldmann H; Kobinger GP
    PLoS One; 2008; 3(10):e3548. PubMed ID: 18958172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus.
    Yoon HA; Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Song HJ; Cho JG; Eo SK
    J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice.
    Farnós O; Rodríguez M; Chiong M; Parra F; Boué O; Lorenzo N; Colás M; Lleonart R
    Vet Microbiol; 2006 May; 114(3-4):187-95. PubMed ID: 16384666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery.
    Shi W; Ji Y; Zhang X; Shu S; Wu Z
    J Pharm Sci; 2011 Mar; 100(3):886-95. PubMed ID: 20862775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxypropyltrimethyl ammonium chloride chitosan-based hydrogel as the split H5N1 mucosal adjuvant: Structure-activity relationship.
    Fan Q; Miao C; Huang Y; Yue H; Wu A; Wu J; Wu J; Ma G
    Carbohydr Polym; 2021 Aug; 266():118139. PubMed ID: 34044953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate.
    Wu J; Su ZG; Ma GH
    Int J Pharm; 2006 Jun; 315(1-2):1-11. PubMed ID: 16616819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms.
    Chen CY; Liu HJ; Tsai CP; Chung CY; Shih YS; Chang PC; Chiu YT; Hu YC
    Vaccine; 2010 Nov; 28(48):7644-51. PubMed ID: 20883735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
    Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
    Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs.
    Richardson JS; Abou MC; Tran KN; Kumar A; Sahai BM; Kobinger GP
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1032-42. PubMed ID: 21987739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.